Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Betting on human antibody providers

Human antibodies are a hot topic, and most of the attention has gone to Abgenix Inc.'s technology. But two other public companies - Medarex Inc. (MEDX) and Cambridge Antibody Technology Group plc (LSE:CAT) - also are players, each providing a slightly different way of generating

Read the full 458 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers